DaShenLin Pharmaceutical Group Co., Ltd.
603233Biotechnology
CN¥20.26+9.99%As of Oct 30vs prior close
- Market cap
- $3.6B
- P/E (TTM)
- 16.2×
- P/E (FY1)
- 15.5×
- From 52W high
- 0.00%
- EPS (LTM)
- CN¥1.19
- Revenue (LTM)
- CN¥28B
- Net margin
- 4.88%
Nomior Score
57
Steady ProfileTop 33% of the scored universe
Growth58
Quality59
Value61
Momentum—
Resilience46
Growth
+8.98%revenue a year over 3 fiscal years
YE22 CN¥21.2BLTM CN¥28B
Connections
Revenue to profitYE25
4% of revenue became net profit, up 1 pt on a year.